Jiangsu Hengrui Medicine Co Ltd Sustainability Reports
Jiangsu Hengrui Medicine Co., Ltd. is an innovative global pharmaceutical company based in China that develops, manufactures, and distributes healthcare products. The company focuses primarily on antineoplastics, surgical medications, contrast agents, cardiovascular drugs, and pain relievers.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
LEI: 2549003BT1XS3SE3E448
FIGI: BBG001SG7CK5
8 reports from 2021 to 2025
- Jiangsu Hengrui Medicine Co Ltd 2025 Environmental, Social and Governance Report
- Jiangsu Hengrui Medicine Co Ltd 2025 Annual Report
- Jiangsu Hengrui Medicine Co Ltd 2024 Environmental, Social and Governance Report
- Jiangsu Hengrui Medicine Co Ltd 2024 Environmental, Social and Governance Report
- Jiangsu Hengrui Medicine Co Ltd 2023 Environmental, Social and Governance (ESG) Report